Literature DB >> 11078031

How fast are antidepressants?

A J Gelenberg1, C L Chesen.   

Abstract

BACKGROUND: For years, investigators have tried to determine the speed of onset of antidepressant drugs. Claims that particular drugs may produce a faster response in patients than other agents have been made, but such claims have never been confirmed.
METHOD: The authors reviewed reports from studies of the speed of onset of antidepressant therapies and other studies that revealed information on this topic. We compiled a list of factors that can affect the results of such studies and interpretations of study results. In addition, we reviewed literature concerned with methods of speeding up antidepressant responses.
RESULTS: No antidepressant medication currently available has been shown conclusively to have a more rapid onset of action than any other. However, some methods of augmentation may have the potential to speed responses. Somatic therapies such as electroconvulsive therapy, phototherapy, and therapeutic sleep deprivation may be the fastest options available at this time.
CONCLUSION: All available antidepressant medications are usually taken for several weeks before future responders will display a significant therapeutic benefit. If a patient does not show at least a 20% improvement within the first 2 to 4 weeks of treatment, the treatment regimen should be altered. For patients who do show early benefits from a medication trial, one can expect additional benefits to accrue over an 8- to 12-week period and to improve overall outcome compared with those slower to respond. Future trials need to address methodological confounds, but a truly "faster antidepressant" will probably require new neuroscience technology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078031     DOI: 10.4088/jcp.v61n1002

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  23 in total

Review 1.  Third-generation antidepressants: do they offer advantages over the SSRIs?

Authors:  J S Olver; G D Burrows; T R Norman
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

Authors:  David E Kemp; Stephen J Ganocy; Martin Brecher; Berit X Carlson; Suzanne Edwards; James M Eudicone; Gary Evoniuk; Wim Jansen; Andrew C Leon; Margaret Minkwitz; Andrei Pikalov; Hans H Stassen; Armin Szegedi; Mauricio Tohen; Arjen P P Van Willigenburg; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2010-11-10       Impact factor: 4.839

3.  Who receives antidepressants and what impact do they have? An acute-care study.

Authors:  Patricia M Averill; Adel A Wassef
Journal:  Psychiatr Q       Date:  2006

Review 4.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

5.  Relief of expressed suicidal intent by ECT: a consortium for research in ECT study.

Authors:  Charles H Kellner; Max Fink; Rebecca Knapp; Georgios Petrides; Mustafa Husain; Teresa Rummans; Martina Mueller; Hilary Bernstein; Keith Rasmussen; Kevin O'connor; Glenn Smith; A John Rush; Melanie Biggs; Shawn McClintock; Samuel Bailine; Chitra Malur
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

6.  Grape-derived polyphenols produce antidepressant effects via VGF- and BDNF-dependent mechanisms.

Authors:  Cheng Jiang; Emmy Sakakibara; Wei-Jye Lin; Jun Wang; Giulio M Pasinetti; Stephen R Salton
Journal:  Ann N Y Acad Sci       Date:  2019-05-10       Impact factor: 5.691

7.  Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

Authors:  Zaorui Zhao; Han-Ting Zhang; Elianna Bootzin; Mark J Millan; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

8.  Fast-scan cyclic voltammetry analysis of dynamic serotonin reponses to acute escitalopram.

Authors:  Kevin M Wood; Parastoo Hashemi
Journal:  ACS Chem Neurosci       Date:  2013-04-24       Impact factor: 4.418

Review 9.  Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.

Authors:  Ja Wook Koo; Ronald S Duman
Journal:  Curr Opin Investig Drugs       Date:  2009-07

10.  Rapid antidepressant effects: moving right along.

Authors:  K Martinowich; D V Jimenez; C A Zarate; H K Manji
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.